Cells deficient in hENT1 are highly resistant to gemcitabine (Mackey et al, 2003) while hCNT1 transfection increases gemcitabine sensitivity in pancreatic cancer cell lines (Garcia-Manteiga et al, 2003). This evidence concerns the gene SLC29A1 and pancreatic neoplasm.